Research Articles

Canadian Cardiovascular Society Guidelines for Evaluation and Management of Cardiovascular Complications of Cancer Therapy

Authors: Sean A. Virani, MD, MSc, MPH, FRCPC (Co-Chair, Primary Panel)∗,correspondencePress enter key for correspondence informationemailPress enter key to Email the author, Susan Dent, MD, FRCPC (Co-Chair, Primary Panel)∗, Christine Brezden-Masley, MD, PhD, FRCPC (Primary Panel), Brian Clarke, MD, FRCPC, FACC (Primary Panel), Margot K. Davis, MD, FRCPC (Primary Panel), Davinder S. Jassal, MD, FACC, FRCPC (Primary Panel), Christopher Johnson, MD, FRCPC (Primary Panel), Julie Lemieux, MD, MSc, FRCPC (Primary Panel), Ian Paterson, MD, FRCPC (Primary Panel), Igal A. Sebag, MD, FRCPC, FACC, FASE (Primary Panel), Christine Simmons, MD, MSc, FRCPC (Primary Panel), Jeffrey Sulpher, MD, FRCPC (Primary Panel), Kishore Thain, MD, FRCPC (Primary Panel), Paaldinesh Thavendiranathan, MD, MSc, FRCPC (Primary Panel), Jason R. Wentzell, BScPharm, ACPR (Primary Panel), Nola Wurtele, MN, NP(A) (Primary Panel), Marc André Côté, MD, FRCPC (Secondary Panel), Nowell M. Fine, MD, MS, FRCPC (Secondary Panel), Haissam Haddad, MD, FRCPC, FACC (Secondary Panel), Bradley D. Hayley, MD, FRCPC (Secondary Panel), Sean Hopkins, BSc (Hon), BSP (Secondary Panel), Anil A. Joy, MD (Secondary Panel), Daniel Rayson, MD, FRCPC, FACP (Secondary Panel), Ellamae Stadnick, MD, MSc, FRCPC (Secondary Panel), Lynn Straatman, MD, FRCPC (Secondary Panel)
Publication: Canadian Journal of Cardiology
Date: July 2016
URL: http://www.onlinecjc.ca/article/S0828-282X(16)30004-6/abstract

Breast Cancer Chemotherapy and Your Heart

Authors: Christine Unitt, Kamaneh Montazeri, Sara Tolaney, Javid Moslehi
Publication: Circulation
Date: 2014
URL: http://circ.ahajournals.org/content/129/25/e680.full

ABCDE Steps to Prevent Heart Disease in Breast Cancer Survivors

Authors: Kamaneh Montazeri, Christine Unitt, JoAnne M. Foody, Jay R. Harris, Ann H. Partridge and Javid Moslehi
Publication: Circulation
Date: 2014
URL: http://circ.ahajournals.org/content/130/18/e157.extract

Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors: Lipshultz SE, Diamond MB, Franco VI, Aggarwal S, Leger K, Santos MV, Sallan SE, Chow EJ.
Publication: Paediatric Drugs
Date: 2014 Oct
URL: http://link.springer.com/article/10.1007%2Fs40272-014-0085-1

Non-pegylated liposome-encapsulated doxorubicin citrate plus cyclophosphamide or vinorelbine in metastatic breast cancer not previously treated with chemotherapy: A multicenter phase III study.

Authors: Lorusso V, Giotta F, Bordonaro R, Maiello E, Del Prete S, Gebbia V, Filippelli G, Pisconti S, Cinieri S, Romito S, Riccardi F, Forcignanò R, Ciccarese M, Petrucelli L, Saracino V, Lupo LI, Gambino A, Leo S.
Publication: International Journal of Oncology
Date: 2014 Nov
URL: http://www.spandidos-publications.com/ijo/45/5/2137

Mitochondrial catastrophe during doxorubicin-induced cardiotoxicity: A review of the protective role of melatonin.

Authors: Govender J, Loos B, Marais E, Engelbrecht AM.
Publication: Journal of Pineal Res
Date: 2014 Sep 17
URL: http://www.ncbi.nlm.nih.gov/pubmed/25230823

Mitochondrial topoisomerase I (top1mt) is a novel limiting factor of Doxorubicin cardiotoxicity.

Authors: Khiati S, Dalla Rosa I, Sourbier C, Ma X, Rao VA, Neckers LM, Zhang H, Pommier Y.
Publication: Clinical Cancer Research
Date: 2014 Sep 15
URL: http://clincancerres.aacrjournals.org/content/20/18/4873.long